NEWS

August 21, 2024

Notice of Address Change

READ MORE

August 07, 2024

Xeureka begins AI drug discovery support for FunPep research on antibody-inducing peptides

READ MORE

May 02, 2024

【Case study】Target Analysis

READ MORE

February 01, 2024

Mitsui & Co. Subsidiary, Xeureka, Launches Tokyo-1 Project Propelling AI-Driven Drug Discovery

READ MORE

January 16, 2024

【Case study】Ultra Large Scale Virtual Screening

READ MORE

May 31, 2023

Xeureka Accelerates AI Drug Discovery with Cutting-edge Supercomputer Powered by NVIDIA, Launches Tokyo-1 Project for Leading Pharmaceutical Companies in Japan

READ MORE

November 11, 2021

Establishment of AI-driven Drug Discovery Company

READ MORE